XTorial With Patients and Caregivers (Q&A)

Share

Program Content

Activities

  • Novel ADCs in Breast Cancer
    Expert Perspectives on Novel and Emerging HER2-Directed and TROP-2‒Targeted ADCs for Advanced Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 02, 2024

    Expires: May 01, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.